Stieger B - Search Results

1

Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.

Annaert P, Ye ZW, Stieger B, Augustijns P. Annaert P, et al. Among authors: stieger b. Xenobiotica. 2010 Mar;40(3):163-76. doi: 10.3109/00498250903509375. Xenobiotica. 2010. PMID: 20102298

2

Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green.

de Graaf W, Häusler S, Heger M, van Ginhoven TM, van Cappellen G, Bennink RJ, Kullak-Ublick GA, Hesselmann R, van Gulik TM, Stieger B. de Graaf W, et al. Among authors: stieger b. J Hepatol. 2011 Apr;54(4):738-45. doi: 10.1016/j.jhep.2010.07.047. Epub 2010 Oct 1. J Hepatol. 2011. PMID: 21163547

3

Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump.

Mita S, Suzuki H, Akita H, Stieger B, Meier PJ, Hofmann AF, Sugiyama Y. Mita S, et al. Among authors: stieger b. Am J Physiol Gastrointest Liver Physiol. 2005 Jan;288(1):G159-67. doi: 10.1152/ajpgi.00360.2003. Epub 2004 Aug 5. Am J Physiol Gastrointest Liver Physiol. 2005. PMID: 15297262

4

Clearance Prediction of HIV Protease Inhibitors in Man: Role of Hepatic Uptake.

De Bruyn T, Stieger B, Augustijns PF, Annaert PP. De Bruyn T, et al. Among authors: stieger b. J Pharm Sci. 2016 Feb;105(2):854-863. doi: 10.1002/jps.24564. Epub 2016 Jan 11. J Pharm Sci. 2016. PMID: 26213315

5

Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin.

Wlcek K, Koller F, Ferenci P, Stieger B. Wlcek K, et al. Among authors: stieger b. Drug Metab Dispos. 2013 Aug;41(8):1522-8. doi: 10.1124/dmd.113.051037. Epub 2013 May 21. Drug Metab Dispos. 2013. PMID: 23695864

6

Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine.

Nicolaï J, Thevelin L, Bing Q, Stieger B, Chanteux H, Augustijns P, Annaert P. Nicolaï J, et al. Among authors: stieger b. Pharm Res. 2017 Nov;34(11):2336-2348. doi: 10.1007/s11095-017-2241-0. Epub 2017 Aug 21. Pharm Res. 2017. PMID: 28828541

7

Structure-based identification of OATP1B1/3 inhibitors.

De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP. De Bruyn T, et al. Among authors: stieger b. Mol Pharmacol. 2013 Jun;83(6):1257-67. doi: 10.1124/mol.112.084152. Epub 2013 Apr 9. Mol Pharmacol. 2013. PMID: 23571415

8

Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition.

De Bruyn T, Sempels W, Snoeys J, Holmstock N, Chatterjee S, Stieger B, Augustijns P, Hofkens J, Mizuno H, Annaert P. De Bruyn T, et al. Among authors: stieger b. J Pharm Sci. 2014 Jun;103(6):1872-81. doi: 10.1002/jps.23933. Epub 2014 Mar 20. J Pharm Sci. 2014. PMID: 24652646

9

Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.

Treiber A, Schneiter R, Häusler S, Stieger B. Treiber A, et al. Among authors: stieger b. Drug Metab Dispos. 2007 Aug;35(8):1400-7. doi: 10.1124/dmd.106.013615. Epub 2007 May 11. Drug Metab Dispos. 2007. PMID: 17496208

10

Efflux and uptake transporters involved in the disposition of bazedoxifene.

Lušin TT, Mrhar A, Stieger B, Kristl A, Berginc K, Trontelj J. Lušin TT, et al. Among authors: stieger b. Eur J Drug Metab Pharmacokinet. 2016 Jun;41(3):251-7. doi: 10.1007/s13318-015-0256-7. Epub 2015 Jan 29. Eur J Drug Metab Pharmacokinet. 2016. PMID: 25631963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results